74.90.Z - Other professional, scientific and technical activities not elsewhere classified
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
47.91.Z - Retail sale via mail order houses or via Internet
62.09.Z - Other information technology and computer service activities
72.11.Z - Research and experimental development on biotechnology
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 19 | 4,9 | 5,6 | 14,9 |
EBITDA | 21,4 | 4,5 | 7,9 | 77,2 |
Short time liabilities | 154,9 | 10 | 15,5 | 54,4 |
Equity capital | 21,8 | 28 | 33,1 | 18,1 |
Operating profit (EBIT) | 20,6 | 4,5 | 7,9 | 77,2 |
Assets | 176,6 | 38 | 48,5 | 27,6 |
Net profit (loss) | 16,8 | 4,4 | 5,1 | 14,1 |
Cash | 15,9 | 17,6 | 19,1 | 8,7 |
Net income from sale | 125 | 136,4 | 312,3 | 129 |
Liabilities and provisions for liabilities | 154,9 | 10 | 15,5 | 54,4 |
Working assets | 176,6 | 38 | 48,5 | 27,6 |
Depreciation | 0,8 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 77 | 15,8 | 15,3 | -0,5 |
Equity capital to total assets | 12,3 | 73,7 | 68,1 | -5,6 |
Gross profit margin | 15,2 | 3,6 | 1,8 | -1,8 |
EBITDA Margin | 17,1 | 3,3 | 2,5 | -0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 452 | 27 | 18 | -9 |
Current financial liquidity indicator | 1.140498161315918 | 3.7962522506713867 | 3.1389102935791016 | -0,7 |
Net dept to EBITDA | 1.2369606494903564 | -3.9438557624816895 | -2.41939115524292 | 1,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane